1. Home
  2. NLSP vs ECDA Comparison

NLSP vs ECDA Comparison

Compare NLSP & ECDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • ECDA
  • Stock Information
  • Founded
  • NLSP 2015
  • ECDA 2013
  • Country
  • NLSP Switzerland
  • ECDA United States
  • Employees
  • NLSP N/A
  • ECDA N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • ECDA Auto Manufacturing
  • Sector
  • NLSP Health Care
  • ECDA Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • ECDA Nasdaq
  • Market Cap
  • NLSP 12.4M
  • ECDA 11.5M
  • IPO Year
  • NLSP 2021
  • ECDA N/A
  • Fundamental
  • Price
  • NLSP $2.68
  • ECDA $0.26
  • Analyst Decision
  • NLSP
  • ECDA
  • Analyst Count
  • NLSP 0
  • ECDA 0
  • Target Price
  • NLSP N/A
  • ECDA N/A
  • AVG Volume (30 Days)
  • NLSP 325.4K
  • ECDA 18.3M
  • Earning Date
  • NLSP 07-07-2025
  • ECDA 08-18-2025
  • Dividend Yield
  • NLSP N/A
  • ECDA N/A
  • EPS Growth
  • NLSP N/A
  • ECDA N/A
  • EPS
  • NLSP N/A
  • ECDA N/A
  • Revenue
  • NLSP N/A
  • ECDA $24,597,358.00
  • Revenue This Year
  • NLSP N/A
  • ECDA $21.59
  • Revenue Next Year
  • NLSP N/A
  • ECDA N/A
  • P/E Ratio
  • NLSP N/A
  • ECDA N/A
  • Revenue Growth
  • NLSP N/A
  • ECDA 3.46
  • 52 Week Low
  • NLSP $1.30
  • ECDA $0.24
  • 52 Week High
  • NLSP $16.00
  • ECDA $1.45
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 62.59
  • ECDA 36.50
  • Support Level
  • NLSP $2.19
  • ECDA $0.29
  • Resistance Level
  • NLSP $2.54
  • ECDA $0.73
  • Average True Range (ATR)
  • NLSP 0.19
  • ECDA 0.06
  • MACD
  • NLSP -0.01
  • ECDA -0.00
  • Stochastic Oscillator
  • NLSP 57.89
  • ECDA 0.40

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About ECDA ECD Automotive Design Inc.

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

Share on Social Networks: